🔎 Trials Near Me

Početna › Ulcerativni kolitis › Massachusetts

Kliničke studije za Ulcerativni kolitis u državi Massachusetts

16 studija za Ulcerativni kolitis traži sudionike na lokacijama u državi Massachusetts.

Gradovi u državi Massachusetts

Službeni tekst studije (engleski)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Lucida Clinical Trials /ID# 282000, New Bedford
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastro Health Research - Framingham, Framingham
  • Lucida Clinical Trials LLC, New Bedford
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06581328

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 003, Boston
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07012395

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Boston Children's Hospital, Boston
  • University of Massachusetts Chan Medical School, Worcester
U tijeku regrutacijaFaza 2/3
Od 2 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Lucida Clinical Trials, New Bedford
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Brigham and Women's Hospital, Boston
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07186101

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Boston Children's Hospital, Boston
  • Massachusetts General Hospital, Waltham
U tijeku regrutacijaFaza 3
Od 2 do 19 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04844606

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Tufts Medical Center - Site Number: 8400126, Boston
  • UMass Memorial Medical Center - Site Number: 8400121, Worcester
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07184996

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • Brigham and Women's Hospital, Boston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT07237516

Treatment of UC With Novel Therapeutics

  • Brigham and Women's Hospital, Chestnut Hill
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 21. srp 2026. · NCT06420375

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • Boston Children's Hospital, Boston
U tijeku regrutacijaFaza 2
Od 12 do 17 godina · Oba spola · Ažurirano 8. srp 2026. · NCT05287126

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • Massachusetts General Hospital, Boston
U tijeku regrutacija
Od 18 do 85 godina · Oba spola · Ažurirano 8. sij 2026. · NCT05987852

Study of Novel Therapeutics for Acute Remedy of Colitis

  • Brigham and Women's Hospital, Chestnut Hill
  • Brigham and Women's Hospital, Chestnut Hill
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 20. lis 2025. · NCT06420492

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

  • Boston Children's Hospital, Boston
U tijeku regrutacijaOpažajna studija
Od 5 do 25 godina · Oba spola · Ažurirano 3. ožu 2025. · NCT04331639

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

  • Massachusetts General Hospital, Boston
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 14 godina i više · Oba spola · Ažurirano 20. pro 2024. · NCT06655415

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.